Annual FCF
-$10.84 M
+$6.19 M+36.35%
31 December 2023
Summary:
ProMIS Neurosciences annual free cash flow is currently -$10.84 million, with the most recent change of +$6.19 million (+36.35%) on 31 December 2023. During the last 3 years, it has fallen by -$7.34 million (-209.80%). PMN annual FCF is now -856.40% below its all-time high of -$1.13 million, reached on 01 December 2015.PMN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$6.67 M
-$5.17 M-343.41%
30 September 2024
Summary:
ProMIS Neurosciences quarterly free cash flow is currently -$6.67 million, with the most recent change of -$5.17 million (-343.41%) on 30 September 2024. Over the past year, it has dropped by -$4.29 million (-180.71%). PMN quarterly FCF is now -9630.14% below its all-time high of $70.00 thousand, reached on 01 September 2010.PMN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$22.23 M
-$4.29 M-23.95%
30 September 2024
Summary:
ProMIS Neurosciences TTM free cash flow is currently -$22.23 million, with the most recent change of -$4.29 million (-23.95%) on 30 September 2024. Over the past year, it has dropped by -$10.59 million (-90.95%). PMN TTM FCF is now -14560.42% below its all-time high of -$151.60 thousand, reached on 01 June 2005.PMN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMN Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.4% | -180.7% | -91.0% |
| 3 y3 years | -209.8% | -120.1% | -262.7% |
| 5 y5 years | -70.9% | -941.5% | -309.1% |
PMN Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -209.8% | +36.4% | -343.4% | +35.2% | -262.7% | at low |
| 5 y | 5 years | -209.8% | +36.4% | -941.5% | +35.2% | -573.6% | at low |
| alltime | all time | -856.4% | +36.4% | -9630.1% | +35.2% | <-9999.0% | at low |
ProMIS Neurosciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.67 M(+343.4%) | -$22.23 M(+24.0%) |
| June 2024 | - | -$1.50 M(-85.4%) | -$17.93 M(-3.5%) |
| Mar 2024 | - | -$10.29 M(+173.8%) | -$18.57 M(+71.3%) |
| Dec 2023 | -$10.84 M(-36.3%) | -$3.76 M(+58.1%) | -$10.84 M(-6.8%) |
| Sept 2023 | - | -$2.38 M(+10.7%) | -$11.64 M(-16.3%) |
| June 2023 | - | -$2.15 M(-16.2%) | -$13.90 M(-14.4%) |
| Mar 2023 | - | -$2.56 M(-43.7%) | -$16.23 M(-4.7%) |
| Dec 2022 | -$17.04 M(+83.0%) | -$4.55 M(-1.8%) | -$17.04 M(+3.0%) |
| Sept 2022 | - | -$4.64 M(+3.5%) | -$16.53 M(+10.7%) |
| June 2022 | - | -$4.48 M(+32.9%) | -$14.93 M(+25.4%) |
| Mar 2022 | - | -$3.37 M(-16.9%) | -$11.90 M(+27.8%) |
| Dec 2021 | -$9.31 M(+166.0%) | -$4.05 M(+33.6%) | -$9.31 M(+52.0%) |
| Sept 2021 | - | -$3.03 M(+108.9%) | -$6.13 M(+60.4%) |
| June 2021 | - | -$1.45 M(+86.6%) | -$3.82 M(+15.8%) |
| Mar 2021 | - | -$777.50 K(-10.4%) | -$3.30 M(-5.7%) |
| Dec 2020 | -$3.50 M(-24.9%) | -$867.90 K(+19.7%) | -$3.50 M(-6.8%) |
| Sept 2020 | - | -$725.10 K(-21.9%) | -$3.76 M(+2.3%) |
| June 2020 | - | -$929.00 K(-5.0%) | -$3.67 M(-5.3%) |
| Mar 2020 | - | -$978.20 K(-12.9%) | -$3.88 M(-16.8%) |
| Dec 2019 | -$4.66 M(-26.5%) | - | - |
| Dec 2019 | - | -$1.12 M(+75.4%) | -$4.66 M(-14.2%) |
| Sept 2019 | - | -$640.50 K(-43.6%) | -$5.43 M(-18.5%) |
| June 2019 | - | -$1.14 M(-35.5%) | -$6.67 M(-3.1%) |
| Mar 2019 | - | -$1.76 M(-7.0%) | -$6.88 M(+8.4%) |
| Dec 2018 | -$6.35 M(+40.0%) | - | - |
| Dec 2018 | - | -$1.89 M(+1.2%) | -$6.35 M(+12.1%) |
| Sept 2018 | - | -$1.87 M(+38.7%) | -$5.66 M(+11.6%) |
| June 2018 | - | -$1.35 M(+9.9%) | -$5.07 M(+5.9%) |
| Mar 2018 | - | -$1.23 M(+1.7%) | -$4.79 M(+5.7%) |
| Dec 2017 | -$4.53 M(+139.5%) | -$1.21 M(-5.9%) | -$4.53 M(+17.2%) |
| Sept 2017 | - | -$1.28 M(+20.1%) | -$3.87 M(+26.4%) |
| June 2017 | - | -$1.07 M(+10.3%) | -$3.06 M(+23.2%) |
| Mar 2017 | - | -$970.00 K(+78.7%) | -$2.48 M(+31.1%) |
| Dec 2016 | -$1.89 M(+66.9%) | -$542.90 K(+14.1%) | -$1.89 M(+13.6%) |
| Sept 2016 | - | -$475.90 K(-3.5%) | -$1.67 M(-11.5%) |
| June 2016 | - | -$493.10 K(+29.6%) | -$1.88 M(+28.5%) |
| Mar 2016 | - | -$380.60 K(+20.1%) | -$1.47 M(+29.2%) |
| Dec 2015 | -$1.13 M | -$317.00 K(-54.2%) | -$1.13 M(+38.8%) |
| Sept 2015 | - | -$692.80 K(+826.2%) | -$816.80 K(+95.3%) |
| June 2015 | - | -$74.80 K(+52.0%) | -$418.20 K(-55.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | -$49.20 K(-83.3%) | -$935.00 K(-46.6%) |
| Dec 2014 | -$1.18 M(-27.4%) | - | - |
| Sept 2014 | - | -$294.20 K(-50.3%) | -$1.75 M(+9.7%) |
| June 2014 | - | -$591.60 K(-23.7%) | -$1.60 M(-1.9%) |
| Mar 2014 | -$1.63 M(-17.5%) | -$774.90 K(+756.2%) | -$1.63 M(+50.9%) |
| Dec 2013 | - | -$90.50 K(-35.1%) | -$1.08 M(-24.4%) |
| Sept 2013 | - | -$139.40 K(-77.6%) | -$1.43 M(-25.8%) |
| June 2013 | - | -$622.40 K(+175.8%) | -$1.92 M(-2.5%) |
| Mar 2013 | -$1.97 M(-15.7%) | -$225.70 K(-48.6%) | -$1.97 M(-16.7%) |
| Dec 2012 | - | -$438.70 K(-30.9%) | -$2.37 M(-6.7%) |
| Sept 2012 | - | -$635.30 K(-5.5%) | -$2.54 M(+10.8%) |
| June 2012 | - | -$672.50 K(+8.3%) | -$2.29 M(-2.1%) |
| Mar 2012 | -$2.34 M(+0.3%) | -$621.00 K(+1.8%) | -$2.34 M(-7.2%) |
| Dec 2011 | - | -$609.90 K(+57.6%) | -$2.52 M(-1.2%) |
| Sept 2011 | - | -$387.00 K(-46.4%) | -$2.55 M(+21.8%) |
| June 2011 | - | -$722.50 K(-10.0%) | -$2.10 M(-10.1%) |
| Mar 2011 | -$2.33 M(-41.2%) | -$803.20 K(+25.3%) | -$2.33 M(-16.0%) |
| Dec 2010 | - | -$640.80 K(-1015.4%) | -$2.78 M(-9.0%) |
| Sept 2010 | - | $70.00 K(-107.3%) | -$3.05 M(-27.1%) |
| June 2010 | - | -$959.00 K(-23.1%) | -$4.18 M(+5.4%) |
| Mar 2010 | -$3.97 M(+18.1%) | -$1.25 M(+36.3%) | -$3.97 M(+28.3%) |
| Dec 2009 | - | -$914.40 K(-14.0%) | -$3.09 M(+23.9%) |
| Sept 2009 | - | -$1.06 M(+42.7%) | -$2.50 M(+5.5%) |
| June 2009 | - | -$744.60 K(+100.8%) | -$2.37 M(-29.6%) |
| Mar 2009 | -$3.36 M(-43.0%) | -$370.80 K(+16.8%) | -$3.36 M(-18.7%) |
| Dec 2008 | - | -$317.40 K(-66.0%) | -$4.13 M(-23.6%) |
| Sept 2008 | - | -$932.40 K(-46.4%) | -$5.41 M(-11.8%) |
| June 2008 | - | -$1.74 M(+52.1%) | -$6.13 M(+4.0%) |
| Mar 2008 | -$5.90 M(+88.7%) | -$1.14 M(-28.2%) | -$5.90 M(-0.6%) |
| Dec 2007 | - | -$1.59 M(-3.6%) | -$5.93 M(+20.7%) |
| Sept 2007 | - | -$1.65 M(+9.8%) | -$4.91 M(+23.6%) |
| June 2007 | - | -$1.51 M(+28.0%) | -$3.98 M(+27.2%) |
| Mar 2007 | -$3.13 M(+122.1%) | -$1.18 M(+103.8%) | -$3.13 M(+30.5%) |
| Dec 2006 | - | -$577.30 K(-19.3%) | -$2.39 M(+5.2%) |
| Sept 2006 | - | -$715.80 K(+9.2%) | -$2.28 M(+19.1%) |
| June 2006 | - | -$655.20 K(+46.8%) | -$1.91 M(+35.8%) |
| Mar 2006 | -$1.41 M | -$446.20 K(-2.7%) | -$1.41 M(+46.5%) |
| Dec 2005 | - | -$458.50 K(+30.8%) | -$960.60 K(+91.3%) |
| Sept 2005 | - | -$350.50 K(+131.2%) | -$502.10 K(+231.2%) |
| June 2005 | - | -$151.60 K | -$151.60 K |
FAQ
- What is ProMIS Neurosciences annual free cash flow?
- What is the all time high annual FCF for ProMIS Neurosciences?
- What is ProMIS Neurosciences annual FCF year-on-year change?
- What is ProMIS Neurosciences quarterly free cash flow?
- What is the all time high quarterly FCF for ProMIS Neurosciences?
- What is ProMIS Neurosciences quarterly FCF year-on-year change?
- What is ProMIS Neurosciences TTM free cash flow?
- What is the all time high TTM FCF for ProMIS Neurosciences?
- What is ProMIS Neurosciences TTM FCF year-on-year change?
What is ProMIS Neurosciences annual free cash flow?
The current annual FCF of PMN is -$10.84 M
What is the all time high annual FCF for ProMIS Neurosciences?
ProMIS Neurosciences all-time high annual free cash flow is -$1.13 M
What is ProMIS Neurosciences annual FCF year-on-year change?
Over the past year, PMN annual free cash flow has changed by +$6.19 M (+36.35%)
What is ProMIS Neurosciences quarterly free cash flow?
The current quarterly FCF of PMN is -$6.67 M
What is the all time high quarterly FCF for ProMIS Neurosciences?
ProMIS Neurosciences all-time high quarterly free cash flow is $70.00 K
What is ProMIS Neurosciences quarterly FCF year-on-year change?
Over the past year, PMN quarterly free cash flow has changed by -$4.29 M (-180.71%)
What is ProMIS Neurosciences TTM free cash flow?
The current TTM FCF of PMN is -$22.23 M
What is the all time high TTM FCF for ProMIS Neurosciences?
ProMIS Neurosciences all-time high TTM free cash flow is -$151.60 K
What is ProMIS Neurosciences TTM FCF year-on-year change?
Over the past year, PMN TTM free cash flow has changed by -$10.59 M (-90.95%)